March 24. 2020. Brussels, Belgium. Inotrem will attend the 40th International Symposium on Intensive Care & Emergency Medicine which stands as one of the largest meeting in its field, attracting more than 6200 participants. During the Symposium, Inotrem will present a poster showing for the first time the association between
February 27-28, 2020. Washington DC. Inotrem will attend the 3CT Workshop (Critical Care Clinical Trialists) that will take place at the French Embassy on February 27th and 28th 2020 in Washington DC. During the 2-days Symposium, Inotrem will present the design of its ASTONISH Phase IIb clinical trial for Nangibotide
January 13-16, 2020. San Francisco. Inotrem will participate to the annual J.P. Morgan Healthcare Conference. It is the largest and most informative healthcare investment symposium in the industry, bringing together industry leaders, emerging fast-growth companies, innovative technology creators, and members of the investment community.
December 3, 2019. Nancy. Cecile Jouclas, Inotrem’s Administrative and Financial Officer, will participate to the Deeptech Tour organized by the BPI. Cecile will be a host at the workshop “What tools to finance your deeptech project?” that will take place on the Université de Lorraine’s campus. Throughout France, the Deeptech
October 8-12 in Chania, Crete, Greece. Marc Derive, Co-founder and CSO of Inotrem, will present new preclinical data during the 18th ESS congress and 9th Congress of the IFSS, entitled “TREM-1 pharmacological inhibition by LR12/nangibotide improves survival and controls vascular leakage during experimental endotoxic shock in mice” in a session
28 September – 2 October 2019 in Berlin, Germany. European Society of Intensive Care Medicine’s (ESICM) annual congress attracts audiences of over 6,000 physicians, anesthetists, trainees and nursing and allied health professionals, every year, from every continent and 97 different countries. A diverse faculty of more than 300 international speakers
June 17. 2019 in Paris (La Défense). Dr. Margarita Salcedo Magguilli, CDP at Inotrem, will be speaking at the roundtable “New regulatory paths to innovation” during the 3rd Biotech Meeting Day (Les Rencontres de la Biotech) organized by Pharmaceutiques.
February 19. 2019 in Paris. Martin Koch, COO of Inotrem, participates to “Market Access and Biotechnologies”, a panel discussion organized by France Biotech, France’s main non-profit organization which brings together the country’s leading innovative health companies and their expert partners. www.france-biotech.fr
January 23.-26. 2019 in Paris. Reanimation 2019 is the Annual congress organized by the French Intensive Care Society (www.srlf.org). Dr. Bruno François, Coordinating Physician at the CHU of Limoges, will present the MOT-C-201 Clinical Trial Results regarding safety and tolerability of nangibotide (LR12) in patients with septic shock. www.reanimation-lecongres.com
October 1-3, 2018 in Bangkok, Thailand The International Sepsis Forum (ISF) is an international collaboration to reduce the global burden of sepsis guided by prominent academics from around the world. Sepsis 2018 will be held as a joint meeting with the Thai Society of Critical Sepsis 2018 Medicine. http://internationalsepsisforum.com/
October 3-4. 2018 in Basel, Switzerland The 18th Annual Biotech in Europe Forum is recognized as the leading international stage for those interested in investing and partnering in the biotech and life science industry. This highly transactional event draws together an exciting cross-section of early-stage/pre-IPO, late-stage and public companies with leading
November 5-7. 2018 in Copenhagen, Denmark The 23rd annual international partnering conference BIO-Europe offers world-class workshops, panels and active exhibition along with thousands of prescheduled one-to-one meetings make this event an unrivaled forum for companies across the biotech value chain to meet and do business. https://ebdgroup.knect365.com/bioeurope/